doi: 10.1111/j.1365-2125.1982.tb01999.x.
An oral preparation to release drugs in the human colon
- PMID: 7126413
- PMCID: PMC1427636
- DOI: 10.1111/j.1365-2125.1982.tb01999.x
Item in Clipboard
An oral preparation to release drugs in the human colon
Br J Clin Pharmacol.
1982 Sep.
Abstract
1 A colonic delivery system is described to deliver orally ingested drugs to the colon and release them at that site by coating with an acrylic based resin (Eudragit S). The technique is validated using X-ray evidence and serum levels of a convenient marker, sulphapyridine. 2 This colonic delivery system is particularly suitable for drugs such as 5-amino salicylic acid or steroids in the management of patients with colitis.
Similar articles
-
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis.Br J Clin Pharmacol. 1983 Aug;16(2):185-7. doi: 10.1111/j.1365-2125.1983.tb04983.x. Br J Clin Pharmacol. 1983. PMID: 6615691 Free PMC article.
-
Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.Clin Pharmacokinet. 1985 Jul-Aug;10(4):285-302. doi: 10.2165/00003088-198510040-00001. Clin Pharmacokinet. 1985. PMID: 2864155 Review.
-
Technology to obtain sustained release characteristics of drugs after delivered to the colon.J Drug Target. 1999;6(6):439-48. doi: 10.3109/10611869908996850. J Drug Target. 1999. PMID: 10937289
-
Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.J Control Release. 2008 Dec 8;132(2):91-8. doi: 10.1016/j.jconrel.2008.08.008. Epub 2008 Aug 23. J Control Release. 2008. PMID: 18775755
-
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9. doi: 10.1111/j.1365-2036.2006.03069.x. Aliment Pharmacol Ther. 2006. PMID: 16939423 Review.
Cited by
-
Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.Ir J Med Sci. 1999 Oct-Dec;168(4):228-32. doi: 10.1007/BF02944345. Ir J Med Sci. 1999. PMID: 10624358
-
Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.Pharm Res. 2008 Aug;25(8):1828-35. doi: 10.1007/s11095-008-9580-9. Epub 2008 May 9. Pharm Res. 2008. PMID: 18465212
-
Pharmacokinetic Parameters Determination and In Vitro-In Vivo Correlation of Ileocolonic-Targeted pH-Responsive Coated Mini-Tablets of Naproxen.Sci Pharm. 2015 Jun 2;83(4):645-58. doi: 10.3797/scipharm.1503-16. Print 2015 Oct-Dec. Sci Pharm. 2015. PMID: 26839845 Free PMC article.
-
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.Cochrane Database Syst Rev. 2020 Aug 28;8(8):CD000544. doi: 10.1002/14651858.CD000544.pub5. Cochrane Database Syst Rev. 2020. PMID: 32856298 Free PMC article.
-
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD000543. doi: 10.1002/14651858.CD000543.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Aug 12;8:CD000543. doi: 10.1002/14651858.CD000543.pub5. PMID: 27101467 Free PMC article. Updated.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
